The invention relates to an anti-cancer vaccine combination. Particularly, the invention relates to a pharmaceutical combination comprising a PD-L1/PD-1 expression inhibitor in combination with a viral antigen-associated vaccine.本發明係關於一種抗癌疫苗組合。特定言之,本發明係關於一種醫藥組合,其包含PD-L1/PD-1表現抑制劑及與病毒抗原相關聯之疫苗的組合。